Exacerbations · patients with chronic obstructive pulmonary disease
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Number of people experiencing at least 1 exacerbation/moderate to severe exacerbation · patients with chronic obstructive pulmonary disease
It is very uncertain whether multi‐component interventions (with telehealth as a component of care) changes number of people experiencing at least 1 exacerbation/moderate to… compared with usual care (very low certainty).
1 finding from 1 review
Time to first exacerbation · patients with chronic obstructive pulmonary disease
It is very uncertain whether multi‐component interventions (with telehealth as a component of care) changes time to first exacerbation compared with usual care (very low certainty).
1 finding from 1 review
Quality of life · patients with chronic obstructive pulmonary disease
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
QoL · patients with chronic obstructive pulmonary disease
3 findings from 1 review
no estimate extracted
1 study · 38 participants
Low
no estimate extracted
1 study · 40 participants
Very low
no estimate extracted
2 studies · 203 participants
Very low
CAT score · patients with chronic obstructive pulmonary disease
1 finding from 1 review
Dyspnea · patients with chronic obstructive pulmonary disease
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
No evidence identified · patients with chronic obstructive pulmonary disease
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Transmission‐related outcomes: hospitalization ‐ Number or proportion of hospital admissions · patients with chronic obstructive pulmonary disease
Multi‐component interventions (with telehealth as a component of care) showed no clear difference in number of people who had at least 1 hospital admission compared with usual care (low certainty).
1 finding from 1 review
Number of people re‐admitted (all‐cause) · patients with chronic obstructive pulmonary disease
Multi‐component interventions (with telehealth as a component of care) probably leads to lower number of people re‐admitted (all‐cause) compared with usual care (moderate certainty).
1 finding from 1 review
All‐cause mortality · patients with chronic obstructive pulmonary disease
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Anti‐cytokine, all‐cause mortality ‐ uncertain risk of bias · patients with chronic obstructive pulmonary disease
It is very uncertain whether multi‐component interventions (with telehealth as a component of care) changes mortality (all‐cause) overall analysis compared with usual care (very low certainty).
1 finding from 1 review
Adverse events: number of people with 1 or more (all‐cause) · patients with chronic obstructive pulmonary disease
It is very uncertain whether multi‐component interventions (with telehealth as a component of care) changes adverse events: number of people with 1 or more (all‐cause) compared with usual care (very low certainty).
1 finding from 1 review
Adherence to antipsychotic medication: number of missed doses, average endpoint data, short term (up to 6 months) · People receiving lipid‐lowering medications
Summary of findings table for the comparison of 'intensified patient… probably leads to higher medication adherence at ≤ 6 months compared with 'usual care' (moderate certainty).
1 finding from 1 review
Medication adherence (dichotomous) · People receiving lipid‐lowering medications
Summary of findings table for the comparison of 'intensified patient… leads to higher medication adherence at > 6 months compared with 'usual care' (high certainty).
1 finding from 1 review
LDL‐C reduction (LDL‐C) · People receiving lipid‐lowering medications
1 finding from 1 review
Reduction in total serum cholesterol at ≤ 6 months (mg/dL) · People receiving lipid‐lowering medications
1 finding from 1 review
Reduction in total serum cholesterol at > 6 mos (mg/dL) · People receiving lipid‐lowering medications
1 finding from 1 review
Overall survival · adult cancer survivors from the following cancer sites: breast, colorectal, endometrial, ovarian and prostate cancer
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Time to detection of recurrence · adult cancer survivors from the following cancer sites: breast, colorectal, endometrial, ovarian and prostate cancer
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found